Published in Ophthalmology on February 01, 2006
A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet (2011) 3.55
Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A (2010) 3.33
Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet (2008) 3.29
Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci (2008) 2.91
Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 2.20
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet (2011) 1.98
Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. Ophthalmology (2011) 1.96
Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci (2009) 1.86
Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications. Ophthalmology (2011) 1.81
Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet (2013) 1.77
Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Invest Ophthalmol Vis Sci (2012) 1.63
Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology (2011) 1.61
Association between retinal thickness measured by spectral-domain optical coherence tomography (OCT) and rod-mediated dark adaptation in non-exudative age-related maculopathy. Br J Ophthalmol (2011) 1.48
Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration. Ophthalmology (2011) 1.37
Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.30
Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Ophthalmology (2010) 1.29
Cholesterol in the retina: the best is yet to come. Prog Retin Eye Res (2014) 1.27
ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. Am J Ophthalmol (2010) 1.19
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology (2012) 1.16
Genetic analysis of typical wet-type age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese population. J Ocul Biol Dis Infor (2009) 1.13
Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy. Ophthalmology (2013) 1.08
Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration. Mol Vis (2010) 1.08
Coding variant Met72Thr in the PEDF gene and risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Mol Vis (2009) 1.04
SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Mol Vis (2009) 1.04
Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration. Hum Mol Genet (2014) 1.00
Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach. Eur J Hum Genet (2009) 1.00
Grading of Age-Related Macular Degeneration: Comparison between Color Fundus Photography, Fluorescein Angiography, and Spectral Domain Optical Coherence Tomography. J Ophthalmol (2013) 0.96
Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels. Hum Mol Genet (2015) 0.95
Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration. PLoS One (2014) 0.94
Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates. Invest Ophthalmol Vis Sci (2015) 0.94
Homozygosity for the +674C>T polymorphism on VEGF gene is associated with age-related macular degeneration in a Brazilian cohort. Graefes Arch Clin Exp Ophthalmol (2011) 0.92
Ocular perfusion pressure and choroidal thickness in eyes with polypoidal choroidal vasculopathy, wet-age-related macular degeneration, and normals. Eye (Lond) (2013) 0.92
Mitochondrial DNA haplogroups confer differences in risk for age-related macular degeneration: a case control study. BMC Med Genet (2013) 0.91
Positive association of common variants in CD36 with neovascular age-related macular degeneration. Aging (Albany NY) (2009) 0.89
Vision-threatening retinal abnormalities in chronic kidney disease stages 3 to 5. Clin J Am Soc Nephrol (2011) 0.86
Zinc supplementation inhibits complement activation in age-related macular degeneration. PLoS One (2014) 0.86
Change in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imaging. Invest Ophthalmol Vis Sci (2014) 0.85
A common complement C3 variant is associated with protection against wet age-related macular degeneration in a Japanese population. PLoS One (2011) 0.84
Automated discovery and quantification of image-based complex phenotypes: a twin study of drusen phenotypes in age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 0.83
Idiopathic preretinal glia in aging and age-related macular degeneration. Exp Eye Res (2015) 0.82
Association analysis of genetic and environmental risk factors in the cuticular drusen subtype of age-related macular degeneration. Mol Vis (2012) 0.82
Comparison of drusen area detected by spectral domain optical coherence tomography and color fundus imaging. Invest Ophthalmol Vis Sci (2013) 0.82
Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort study. Am J Clin Nutr (2016) 0.81
Apolipoprotein E gene and age-related macular degeneration in a Chinese population. Mol Vis (2011) 0.81
The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study. PLoS One (2013) 0.81
CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans. Mol Vis (2014) 0.80
Distribution and Quantification of Choroidal Macrophages in Human Eyes With Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci (2016) 0.79
Effect of the Gas6 c.834+7G>A polymorphism and the interaction of known risk factors on AMD pathogenesis in Hungarian patients. PLoS One (2012) 0.79
Differences in the Genetic Susceptibility to Age-Related Macular Degeneration Clinical Subtypes. Invest Ophthalmol Vis Sci (2015) 0.79
Increased choroidal mast cells and their degranulation in age-related macular degeneration. Br J Ophthalmol (2016) 0.78
Small Drusen and Age-Related Macular Degeneration: The Beaver Dam Eye Study. J Clin Med (2015) 0.78
Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study. Am J Clin Nutr (2015) 0.77
In patients with neovascular age-related macular degeneration, physical activity may influence C-reactive protein levels. Clin Ophthalmol (2013) 0.77
Progression Rate From Intermediate to Advanced Age-Related Macular Degeneration Is Correlated With the Number of Risk Alleles at the CFH Locus. Invest Ophthalmol Vis Sci (2016) 0.77
Set-based joint test of interaction between SNPs in the VEGF pathway and exogenous estrogen finds association with age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 0.76
Dynamic Drusen Remodelling in Participants of the Nutritional AMD Treatment-2 (NAT-2) Randomized Trial. PLoS One (2016) 0.76
Systemic and Ocular Long Pentraxin 3 in Patients with Age-Related Macular Degeneration. PLoS One (2015) 0.76
Association between neovascular age-related macular degeneration and dementia: a population-based case-control study in Taiwan. PLoS One (2015) 0.75
Automated Brightness and Contrast Adjustment of Color Fundus Photographs for the Grading of Age-Related Macular Degeneration. Transl Vis Sci Technol (2017) 0.75
Optical Coherence Tomography Monitoring Strategies for A-VEGF-Treated Age-Related Macular Degeneration: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2014) 0.75
Whole exome sequencing of extreme age-related macular degeneration phenotypes. Mol Vis (2016) 0.75
Mapping rare, deleterious mutations in Factor H: Association with early onset, drusen burden, and lower antigenic levels in familial AMD. Sci Rep (2016) 0.75
Genetic Association Analysis of Drusen Progression. Invest Ophthalmol Vis Sci (2016) 0.75
The association between neovascular age-related macular degeneration and regulatory T cells in peripheral blood. Clin Ophthalmol (2015) 0.75
Electrophysiological and clinical tests in dry age-related macular degeneration follow-up: differences between mfERG and OCT. Doc Ophthalmol (2016) 0.75
Peripapillary Choroidal Thickness Change of Polypoidal Choroidal Vasculopathy after Anti-vascular Endothelial Growth Factor. Korean J Ophthalmol (2017) 0.75
Associations Between Vitamin D Intake and Progression to Incident Advanced Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci (2017) 0.75
[Supplements in age-related macular degeneration: recommendations by the German Ophthalmological Society, the German Retina Society and the German Professional Association of Ophthalmologists--October 2014]. Ophthalmologe (2015) 0.75
The incidental findings of age-related macular degeneration during diabetic retinopathy screening. Graefes Arch Clin Exp Ophthalmol (2013) 0.75
Optical Coherence Tomography Features Preceding the Onset of Advanced Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci (2017) 0.75
Neovascular Age-Related Macular Degeneration in the Very Old (≥90 Years): Epidemiology, Adherence to Treatment, and Comparison of Efficacy. J Ophthalmol (2017) 0.75
Altered activation state of circulating neutrophils in patients with neovascular age-related macular degeneration. Immun Ageing (2017) 0.75
Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J (2007) 3.65
Acute-onset floaters and flashes: is this patient at risk for retinal detachment? JAMA (2009) 2.82
Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol (2007) 2.73
Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina (2008) 2.72
Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology (2010) 2.52
Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J (2009) 2.37
Prevalence and significance of an isolated long QT interval in elite athletes. Eur Heart J (2007) 2.28
Utility of the "surprise" question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol (2008) 2.22
Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review. JAMA (2013) 2.19
Angiophagy prevents early embolus washout but recanalizes microvessels through embolus extravasation. Sci Transl Med (2014) 2.11
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol (2003) 2.10
Position paper: proposal for a core curriculum for a European Sports Cardiology qualification. Eur J Prev Cardiol (2012) 2.07
Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green. Ophthalmology (2003) 1.93
Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol (2011) 1.88
The right ventricle of the endurance athlete: the relationship between morphology and deformation. J Am Soc Echocardiogr (2011) 1.85
Health care economic analyses and value-based medicine. Surv Ophthalmol (2003) 1.83
Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med (2009) 1.75
Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol (2008) 1.74
Incremental cost-effectiveness of initial cataract surgery. Ophthalmology (2002) 1.72
Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J Am Coll Cardiol (2008) 1.71
A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet (2004) 1.71
Systematic review and meta-analysis of training mode, imaging modality and body size influences on the morphology and function of the male athlete's heart. Heart (2013) 1.68
Predicting response to glaucoma therapy in one eye based on response in the fellow eye: the monocular trial. Arch Ophthalmol (2008) 1.66
Acute syphilitic posterior placoid chorioretinitis: report of a case series and comprehensive review of the literature. Retina (2012) 1.58
Is intravitreal bevacizumab an effective treatment option for nonarteritic anterior ischemic optic neuropathy? J Neuroophthalmol (2012) 1.54
Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin. Circulation (2013) 1.53
Comparison of electrocardiographic criteria for the detection of cardiac abnormalities in elite black and white athletes. Circulation (2014) 1.53
Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation. Can J Ophthalmol (2010) 1.51
Clinical decisions. Cardiac screening before participation in sports. N Engl J Med (2013) 1.51
Prevalence and significance of T-wave inversions in predominantly Caucasian adolescent athletes. Eur Heart J (2009) 1.50
Value-based medicine: evidence-based medicine and beyond. Ocul Immunol Inflamm (2003) 1.47
Sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol (2008) 1.44
Cost-effectiveness of pre-participation screening of athletes with ECG in Europe and Algeria. Intern Emerg Med (2014) 1.41
Cost-utility analysis of cataract surgery in the second eye. Ophthalmology (2003) 1.41
Evaluating the cost-effectiveness of anterior uveitis investigation by Canadian ophthalmologists. Can J Ophthalmol (2008) 1.40
Support for inclusion of electrocardiography in addition to the Health Questionnaire and Physical Examination in athletic screening protocols for diagnosis of unsuspected hypertrophic cardiomyopathy. Am J Cardiol (2013) 1.39
Effect of small donor weight and donor-recipient weight ratio on the outcome of liver transplantation in children. Pediatr Transplant (2015) 1.38
Electrocardiographic interpretation in athletes: the 'Seattle criteria'. Br J Sports Med (2013) 1.34
Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol (2002) 1.31
Elemental isomerism: a boron-nitrogen surrogate for a carbon-carbon double bond increases the chemical diversity of estrogen receptor ligands. Chem Biol (2007) 1.31
Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology (2003) 1.31
A cost-utility analysis of therapy for amblyopia. Ophthalmology (2002) 1.23
Small cell carcinoma of the esophagus: the Tata Memorial Hospital experience. Ann Thorac Surg (2002) 1.22
The burden of age-related macular degeneration: a value-based analysis. Curr Opin Ophthalmol (2006) 1.21
Cancer cell adaptation to chemotherapy. BMC Cancer (2005) 1.21
The burden of age-related macular degeneration: a value-based medicine analysis. Trans Am Ophthalmol Soc (2005) 1.18
Group motivational interviewing to promote adherence to antiretroviral medications and risk reduction behaviors in HIV infected women. AIDS Behav (2011) 1.17
The effectiveness of isobutyl cyanoacrylate tissue adhesive for the treatment of corneal perforations. Am J Ophthalmol (2005) 1.16
Surgical management of pseudophakic retinal detachments: a meta-analysis. Ophthalmology (2006) 1.16
Should axis deviation or atrial enlargement be categorised as abnormal in young athletes? The athlete's electrocardiogram: time for re-appraisal of markers of pathology. Eur Heart J (2013) 1.16
Tuberculosis in acute leukemia: a clinico-hematological profile. Hematology (2006) 1.14
Environmental strategy and performance in small firms: a resource-based perspective. J Environ Manage (2007) 1.13
Interpretation of the electrocardiogram of young athletes. Circulation (2011) 1.10
Clinical significance of electrocardiographic right ventricular hypertrophy in athletes: comparison with arrhythmogenic right ventricular cardiomyopathy and pulmonary hypertension. Eur Heart J (2013) 1.09
Claudin-19 and the barrier properties of the human retinal pigment epithelium. Invest Ophthalmol Vis Sci (2011) 1.07
Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products. Retrovirology (2006) 1.07
Versatility of the sural fasciocutaneous flap in the coverage of lower extremity wounds. Plast Reconstr Surg (2002) 1.07
Impact of visual impairment on use of caregiving by individuals with age-related macular degeneration. Retina (2006) 1.06
Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. J Cataract Refract Surg (2008) 1.06
Risk factors for progression to penetrating keratoplasty in patients with keratoconus. Am J Ophthalmol (2005) 1.05
The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. Eur Heart J (2011) 1.05
Benign metastasizing meningioma. Jpn J Clin Oncol (2003) 1.05
Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions. Invest Ophthalmol Vis Sci (2009) 1.04
Left ventricular hypertrophy in athletes. Eur J Echocardiogr (2009) 1.03
Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys (2002) 1.03
Visual outcomes and complications of epiretinal membrane removal secondary to rhegmatogenous retinal detachment. Ophthalmology (2005) 1.02
Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains. J Med Chem (2007) 1.01
Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol (2004) 1.01
Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization? Graefes Arch Clin Exp Ophthalmol (2008) 1.01
Acute myocardial infarction in the presence of normal coronaries and the absence of risk factors in a young, lifelong regular exerciser. BMJ Case Rep (2009) 1.01
Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial. Radiology (2007) 1.00
Cardiovascular evaluation of middle-aged/ senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil (2011) 1.00
A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration. Ophthalmology (2007) 1.00
Ubiquitin-proteasome degradation of serum- and glucocorticoid-regulated kinase-1 (SGK-1) is mediated by the chaperone-dependent E3 ligase CHIP. Biochem J (2006) 0.99
Quantitative CT measures of emphysema and airway wall thickness are related to D(L)CO. Respir Med (2010) 0.99
Incidence and characteristics of acute intraocular inflammation after intravitreal injection of bevacizumab: a retrospective cohort study. Can J Ophthalmol (2010) 0.99
Normal electrocardiographic findings: recognising physiological adaptations in athletes. Br J Sports Med (2013) 0.99
TEMPORAL INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE VERSUS CLASSIC INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE: A Comparative Study. Retina (2015) 0.99
Surveillance of disparities in vision and eye health in the United States: an expert panel's opinions. Am J Ophthalmol (2012) 0.98
Troponin release following endurance exercise: is inflammation the cause? a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2010) 0.97
Effects of proinflammatory cytokines on the claudin-19 rich tight junctions of human retinal pigment epithelium. Invest Ophthalmol Vis Sci (2012) 0.97
A cost-utility analysis of interventions for severe proliferative vitreoretinopathy. Am J Ophthalmol (2002) 0.97
Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery. Int J Pharm (2010) 0.97
Health insurance coverage and use of eye care services. Arch Ophthalmol (2008) 0.97
Fibromuscular dysplasia of the renal arteries: a radiological review. Int Urol Nephrol (2006) 0.96
Thoracic duct cyst of the mediastinum. Ann Thorac Cardiovasc Surg (2003) 0.96
Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas. Eur J Cancer (2004) 0.95
Primary colonic liposarcoma causing colo-colic intusussception: a case report and review of literature. J Gastrointest Cancer (2007) 0.95
Mediastinal haematoma: a rare complication following insertion of central venous catheter. Indian J Chest Dis Allied Sci (2011) 0.95
Quality of life and systemic comorbidities in patients with ophthalmic disease. Br J Ophthalmol (2002) 0.94
Preparticipation screening for cardiovascular abnormalities in young competitive athletes. BMJ (2008) 0.94
Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration. Curr Opin Ophthalmol (2011) 0.94
Coexisting pulmonary tuberculosis and mucormycosis in a patient with aplastic anemia post allogenic stem cell transplantation. Mediterr J Hematol Infect Dis (2011) 0.94
Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA). Anticancer Drugs (2003) 0.94
The magnitude of sudden cardiac death in the young: a death certificate-based review in England and Wales. Europace (2009) 0.94
Ortner's syndrome secondary to aortic aneurysm. Ann Acad Med Singapore (2012) 0.93
Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol (2013) 0.93
Patient, community and clinician perceptions of the quality of life associated with diabetes mellitus. Med Sci Monit (2002) 0.92
Synthesis and evaluation of some new benzothiazole derivatives as potential antimicrobial agents. Eur J Med Chem (2010) 0.91